In the current market for food development, the combined experience, expertise and assets from food research and pharma related clinical trials leads to a new proposition to the food industry that includes above-standard quality and cost efficiency and an innovative approach to research projects, which will help our customers to drive their development programs forward with increased focus and speed.

The combined strengths of CHDR, with 25 years of high quality early drug development experience, and TNO, with decades of experience in design, performance and reporting of clinical studies with food (ingredients) ensure high quality, in-time and cost effective performance of a broad array of clinical trials. This alliance provides access to virtually every technique and methodology needed in this field.

Further important assets of the alliance comprise:

Unique human capital, highly experienced staff with expertise in numerous indications

• Experience in both food and pharma clinical trials
• Wide range of validated biomarkers
• Possibility to use microdosing and microtracers
• Leading combination of academic expertise and operational experience
• A large database of volunteers in several age ranges
• Compliance with ICH GCP embedded in a QA system
• 21 CFR part 11 compliant data management system.